Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pituitary Neoplasms | 4 | 2021 | 1322 | 0.840 |
Why?
|
| Meningioma | 5 | 2017 | 1222 | 0.760 |
Why?
|
| Meningeal Neoplasms | 5 | 2017 | 1253 | 0.750 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 3 | 2016 | 132 | 0.590 |
Why?
|
| Hepatectomy | 2 | 2014 | 588 | 0.380 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 1657 | 0.340 |
Why?
|
| Autophagy | 2 | 2017 | 1352 | 0.340 |
Why?
|
| Liver Regeneration | 1 | 2011 | 213 | 0.340 |
Why?
|
| Adenoma | 2 | 2017 | 2155 | 0.320 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 707 | 0.300 |
Why?
|
| Hepatocytes | 2 | 2014 | 1246 | 0.300 |
Why?
|
| Neovascularization, Physiologic | 2 | 2014 | 1376 | 0.300 |
Why?
|
| Endothelial Cells | 3 | 2016 | 3584 | 0.250 |
Why?
|
| Gene Expression | 2 | 2016 | 7581 | 0.240 |
Why?
|
| Macrophages | 3 | 2020 | 5771 | 0.220 |
Why?
|
| Fund Raising | 1 | 2023 | 48 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2017 | 8601 | 0.210 |
Why?
|
| Oxidative Stress | 1 | 2014 | 3139 | 0.210 |
Why?
|
| Genomics | 1 | 2017 | 5926 | 0.180 |
Why?
|
| DNA Copy Number Variations | 3 | 2017 | 2045 | 0.170 |
Why?
|
| Ischemia | 3 | 2016 | 1922 | 0.150 |
Why?
|
| Neuroma, Acoustic | 1 | 2020 | 456 | 0.140 |
Why?
|
| Neurofibromin 2 | 1 | 2017 | 268 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 2454 | 0.130 |
Why?
|
| Hindlimb | 2 | 2014 | 510 | 0.120 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2014 | 132 | 0.120 |
Why?
|
| Glutathione | 2 | 2016 | 589 | 0.120 |
Why?
|
| Immunohistochemistry | 2 | 2021 | 11033 | 0.120 |
Why?
|
| Purinergic P2Y Receptor Agonists | 1 | 2014 | 4 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2017 | 23588 | 0.120 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2014 | 18 | 0.120 |
Why?
|
| Chromosomes, Human | 1 | 2016 | 437 | 0.120 |
Why?
|
| Craniopharyngioma | 1 | 2017 | 276 | 0.120 |
Why?
|
| Cysteine | 2 | 2016 | 898 | 0.110 |
Why?
|
| Oxidoreductases | 1 | 2014 | 409 | 0.100 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 17063 | 0.100 |
Why?
|
| Mice, Mutant Strains | 2 | 2014 | 1746 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2017 | 12767 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2017 | 10428 | 0.100 |
Why?
|
| Mutation | 6 | 2017 | 30188 | 0.090 |
Why?
|
| Telomerase | 1 | 2016 | 749 | 0.090 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 3947 | 0.090 |
Why?
|
| rho-Associated Kinases | 1 | 2012 | 291 | 0.090 |
Why?
|
| Brain Neoplasms | 3 | 2016 | 9069 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2017 | 2924 | 0.090 |
Why?
|
| Microvessels | 1 | 2014 | 589 | 0.090 |
Why?
|
| Transcription Factor AP-1 | 1 | 2011 | 322 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 5 | 2014 | 22323 | 0.080 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2017 | 2057 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 1489 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 15645 | 0.070 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 636 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2021 | 9372 | 0.070 |
Why?
|
| Cell Cycle | 2 | 2014 | 2919 | 0.070 |
Why?
|
| Glycoproteins | 1 | 2014 | 2195 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2014 | 3503 | 0.070 |
Why?
|
| Cell Division | 2 | 2011 | 4471 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 2629 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 9548 | 0.060 |
Why?
|
| Computational Biology | 1 | 2016 | 3557 | 0.060 |
Why?
|
| Cholesterol | 1 | 2012 | 2898 | 0.050 |
Why?
|
| Animals | 9 | 2016 | 168730 | 0.050 |
Why?
|
| Arsenicals | 1 | 2003 | 117 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 3815 | 0.050 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2023 | 123 | 0.050 |
Why?
|
| Cell Movement | 1 | 2014 | 5190 | 0.050 |
Why?
|
| Organizations | 1 | 2023 | 172 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2014 | 4422 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 2878 | 0.050 |
Why?
|
| Oxides | 1 | 2003 | 402 | 0.050 |
Why?
|
| Humans | 13 | 2023 | 765823 | 0.050 |
Why?
|
| Calcium | 1 | 2014 | 5767 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2016 | 3459 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9520 | 0.040 |
Why?
|
| Angioplasty, Balloon | 1 | 2003 | 620 | 0.040 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 2219 | 0.040 |
Why?
|
| Commerce | 1 | 2023 | 611 | 0.040 |
Why?
|
| Models, Biological | 1 | 2014 | 9441 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2003 | 1497 | 0.030 |
Why?
|
| Glutaredoxins | 1 | 2016 | 32 | 0.030 |
Why?
|
| Chromogranins | 1 | 2017 | 160 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2012 | 3421 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2011 | 18970 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 195 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2016 | 268 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2020 | 1890 | 0.030 |
Why?
|
| Mice | 4 | 2014 | 81788 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2017 | 1213 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 419 | 0.030 |
Why?
|
| Radiation Chimera | 1 | 2012 | 216 | 0.030 |
Why?
|
| Foam Cells | 1 | 2012 | 67 | 0.030 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2012 | 63 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2014 | 485 | 0.020 |
Why?
|
| Cyclins | 1 | 2014 | 598 | 0.020 |
Why?
|
| Cholesterol, Dietary | 1 | 2012 | 223 | 0.020 |
Why?
|
| Oncogenes | 1 | 2017 | 1233 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 2012 | 491 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2014 | 733 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2012 | 483 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 1776 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2012 | 643 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2012 | 565 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 1999 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 2141 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2014 | 14445 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 1166 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2016 | 2487 | 0.020 |
Why?
|
| Male | 6 | 2017 | 363740 | 0.020 |
Why?
|
| Apoptosis | 1 | 2003 | 9512 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 6061 | 0.020 |
Why?
|
| Aortic Diseases | 1 | 2012 | 743 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2014 | 2143 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3656 | 0.010 |
Why?
|
| Aorta | 1 | 2012 | 2037 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 2729 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2014 | 4188 | 0.010 |
Why?
|
| Genome, Human | 1 | 2016 | 4445 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 610 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2016 | 4424 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 4961 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 4731 | 0.010 |
Why?
|
| Female | 3 | 2017 | 396050 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 30215 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 59506 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2017 | 81505 | 0.000 |
Why?
|
| Aged | 1 | 2016 | 171178 | 0.000 |
Why?
|
| Middle Aged | 1 | 2016 | 223016 | 0.000 |
Why?
|
| Adult | 1 | 2016 | 223055 | 0.000 |
Why?
|
Concepts
(128)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_